Xcout IntelSign inSubscribe

Karo

PharmaceuticalsSweden

Karo Healthcare is a leading pan-European consumer healthcare company headquartered in Stockholm, Sweden. It boasts a portfolio of well-known brands and has recently changed ownership, with funds managed by KKR acquiring the company from EQT.

Subscribe to see Karo’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Karo at a glance

Karo is a pharmaceuticals company headquartered in Sweden. Its most recent funding round, Pre-Series A, raised $6.7M in June 2026. Xcout tracks 5 named people at Karo, including Joseph Bae (Co-Chief Executive Officer).

Industry
Pharmaceuticals
Headquarters
Sweden

Karo leadership

  • Joseph BaeCo-Chief Executive Officer
  • Scott NuttallCo-Chief Executive Officer
  • George RobertsCo-founder
  • Henry KravisCo-founder
  • Jerome KohlbergCo-founder

Karo funding rounds

Every round on record:

DateRoundAmountInvestors
Pre-Series A$6.7M1 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Investors

Karo competitors

A few of Karo's closest competitors — see the full list of competitors and alternatives →

Perrigo Company plc0Y5E · PharmaceuticalsDublin, Ireland
62% matchPublic

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Market cap$1.8B
Employees8,100
Perrigo Company plc competitors & alternatives →

Get Karo's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Karo — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Karo in Xcout Intel

  • 5 named people with titles, LinkedIn and board committees
  • 1 funding round with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →